Alkem Laboratories Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For ALKEM, that strike is ₹5,050. Spot at ₹5,070 is near max pain — the expiry magnetic pull is active.
Max Pain Level
The current max‑pain strike for Alkem Laboratories Limited (ALKEM) is ₹5,050. This level represents the strike at which the total loss of option writers would be minimized, acting as a magnet that often draws the underlying price toward it as expiry approaches.
Spot vs Max Pain Gap
The spot price of ₹5,070 sits just 0.4 % above the max‑pain level, indicating a narrow bullish gap. Such a small premium suggests limited upside pressure and that the market may pull back toward the ₹5,050 strike as time decay accelerates.
Shift Signal
The max‑pain figure has moved lower by ₹150 relative to yesterday, signaling that option writers are increasingly positioned short the higher strikes. This downward shift implies a growing bias among writers to hedge at lower strikes, which could add downward pressure on the underlying as expiry nears.
Expiry Context
Maximum‑pain theory works by aggregating the open interest in calls and puts, identifying the strike where the combined payout to writers is the smallest. In the final week before expiry, the underlying price often gravitates toward this strike, but the effect is probabilistic, not deterministic. Market participants should view the max‑pain level as a tendency rather than a guaranteed outcome, especially when other macro or company‑specific catalysts are at play.
Data Note
The spot price lies ₹20 above the max‑pain strike with 26 days remaining until the November 23 expiry.
Data as of 2026-10-28